AstraZeneca PLC - Asset Resilience Ratio

Latest as of March 2026: 0.10%

AstraZeneca PLC (AZN) has an Asset Resilience Ratio of 0.10% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of AstraZeneca PLC to assess the company's strategic physical and investment asset allocation.

Liquid Assets

GBX115.00 Million

≈ $13.99K USD Cash + Short-term Investments

Total Assets

GBX114.02 Billion

≈ $13.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1990–2025)

This chart shows how AstraZeneca PLC's Asset Resilience Ratio has changed over time. See AstraZeneca PLC net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down AstraZeneca PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AstraZeneca PLC (AZN) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX115.00 Million	0.1%
Total Liquid Assets	GBX115.00 Million	0.10%

Asset Resilience Insights

Limited Liquidity: AstraZeneca PLC maintains only 0.10% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

AstraZeneca PLC Industry Peers by Asset Resilience Ratio

Compare AstraZeneca PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.48%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Guangdong Jiaying Pharmaceutical Co Ltd SHE:002198	Drug Manufacturers - General	0.46%
Korean Drug Co. Ltd KQ:014570	Drug Manufacturers - General	12.77%
Chorokbaem Healthcare Co Ltd KO:118000	Drug Manufacturers - General	0.11%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%

Annual Asset Resilience Ratio for AstraZeneca PLC (1990–2025)

The table below shows the annual Asset Resilience Ratio data for AstraZeneca PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.03%	GBX30.00 Million ≈ $3.65K	GBX114.07 Billion ≈ $13.88 Million	-0.13pp
2024-12-31	0.16%	GBX165.83 Million ≈ $20.18K	GBX104.03 Billion ≈ $12.66 Million	+0.04pp
2023-12-31	0.12%	GBX120.97 Million ≈ $14.72K	GBX101.12 Billion ≈ $12.30 Million	+0.04pp
2022-12-31	0.08%	GBX77.00 Million ≈ $9.37K	GBX96.48 Billion ≈ $11.74 Million	+0.01pp
2021-12-31	0.07%	GBX68.72 Million ≈ $8.36K	GBX105.36 Billion ≈ $12.82 Million	-0.17pp
2020-12-31	0.24%	GBX159.22 Million ≈ $19.37K	GBX66.73 Billion ≈ $8.12 Million	-1.14pp
2019-12-31	1.38%	GBX849.00 Million ≈ $103.30K	GBX61.38 Billion ≈ $7.47 Million	-0.02pp
2018-12-31	1.40%	GBX849.00 Million ≈ $103.30K	GBX60.65 Billion ≈ $7.38 Million	-0.54pp
2017-12-31	1.94%	GBX1.23 Billion ≈ $149.66K	GBX63.35 Billion ≈ $7.71 Million	+0.53pp
2016-12-31	1.41%	GBX884.00 Million ≈ $107.56K	GBX62.53 Billion ≈ $7.61 Million	+0.39pp
2015-12-31	1.02%	GBX613.00 Million ≈ $74.58K	GBX60.06 Billion ≈ $7.31 Million	+0.99pp
2014-12-31	0.03%	GBX20.00 Million ≈ $2.43K	GBX58.59 Billion ≈ $7.13 Million	-1.43pp
2013-12-31	1.47%	GBX820.48 Million ≈ $99.83K	GBX55.90 Billion ≈ $6.80 Million	-0.07pp
2012-12-31	1.54%	GBX823.00 Million ≈ $100.14K	GBX53.53 Billion ≈ $6.51 Million	-6.50pp
2011-12-31	8.04%	GBX4.25 Billion ≈ $516.86K	GBX52.83 Billion ≈ $6.43 Million	+5.42pp
2010-12-31	2.62%	GBX1.47 Billion ≈ $179.19K	GBX56.13 Billion ≈ $6.83 Million	-0.11pp
2009-12-31	2.73%	GBX1.50 Billion ≈ $182.71K	GBX54.92 Billion ≈ $6.68 Million	+2.51pp
2008-12-31	0.22%	GBX105.00 Million ≈ $12.78K	GBX46.95 Billion ≈ $5.71 Million	-0.14pp
2007-12-31	0.37%	GBX176.67 Million ≈ $21.50K	GBX47.96 Billion ≈ $5.83 Million	-1.83pp
2006-12-31	2.20%	GBX657.29 Million ≈ $79.97K	GBX29.93 Billion ≈ $3.64 Million	-4.36pp
2005-12-31	6.56%	GBX1.63 Billion ≈ $198.18K	GBX24.84 Billion ≈ $3.02 Million	-9.85pp
2004-12-31	16.41%	GBX4.21 Billion ≈ $512.24K	GBX25.65 Billion ≈ $3.12 Million	+2.76pp
2003-12-31	13.65%	GBX3.22 Billion ≈ $391.54K	GBX23.57 Billion ≈ $2.87 Million	-4.71pp
2002-12-31	18.36%	GBX3.96 Billion ≈ $482.06K	GBX21.58 Billion ≈ $2.63 Million	+1.51pp
2001-12-31	16.86%	GBX3.12 Billion ≈ $379.37K	GBX18.50 Billion ≈ $2.25 Million	-1.74pp
2000-12-31	18.60%	GBX3.43 Billion ≈ $417.43K	GBX18.45 Billion ≈ $2.24 Million	+4.17pp
1999-12-31	14.43%	GBX2.86 Billion ≈ $347.86K	GBX19.82 Billion ≈ $2.41 Million	+12.94pp
1998-12-31	1.48%	GBX274.00 Million ≈ $33.34K	GBX18.48 Billion ≈ $2.25 Million	-7.02pp
1997-12-31	8.50%	GBX704.23 Million ≈ $85.68K	GBX8.28 Billion ≈ $1.01 Million	-5.82pp
1996-12-31	14.32%	GBX1.23 Billion ≈ $149.19K	GBX8.56 Billion ≈ $1.04 Million	+1.97pp
1995-12-31	12.35%	GBX971.94 Million ≈ $118.26K	GBX7.87 Billion ≈ $957.52K	+8.36pp
1994-12-31	3.99%	GBX292.36 Million ≈ $35.57K	GBX7.32 Billion ≈ $890.42K	+1.31pp
1993-12-31	2.69%	GBX199.69 Million ≈ $24.30K	GBX7.42 Billion ≈ $903.30K	-0.03pp
1992-12-31	2.72%	GBX168.35 Million ≈ $20.48K	GBX6.19 Billion ≈ $752.91K	-0.10pp
1991-12-31	2.82%	GBX179.63 Million ≈ $21.86K	GBX6.36 Billion ≈ $774.08K	-5.11pp
1990-12-31	7.94%	GBX484.16 Million ≈ $58.91K	GBX6.10 Billion ≈ $742.34K	--

pp = percentage points

About AstraZeneca PLC

LSE:AZN UK Drug Manufacturers - General

Market Cap

$2.50 Billion

GBX20.52 Trillion GBX

Market Cap Rank

#5609 Global

#11 in UK

Share Price

GBX13234.00

Change (1 day)

+0.61%

52-Week Range

GBX10120.00 - GBX15542.00

All Time High

GBX15542.00